Combinatorial Chemistry in Modern Medicinal Chemistry

Abstract

Combinatorial chemistry has revolutionized modern drug discovery by enabling the rapid generation and screening of vast, structurally diverse compound libraries. Built on principles of combinatorial synthesis and high throughput screening, this approach integrates solid phase, solution phase, split mix, and parallel synthesis techniques to efficiently explore chemical space. Advanced strategies such as diversity oriented synthesis, dynamic combinatorial chemistry, and microwave assisted protocols further enhance structural variety, speed, and yield. Computational tools—including virtual screening, molecular docking, QSAR modelling, and fragment based design—complement experimental methods, allowing in silico library construction and prioritization of drug like candidates. Applications span the identification of enzyme inhibitors, selective receptor ligands, and synergistic drug combinations, with innovations like microfluidic droplet based screening reducing scale and cost. Despite challenges in chemical space vastness, predictive accuracy, and synthetic feasibility, combinatorial chemistry remains a cornerstone of medicinal chemistry, offering a systematic, high throughput framework for lead generation, optimization, and integration with biological and computational tools.